Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Viral myocarditis can lead to reduced cardiac function and the progression to dilated cardiomyopathy (DCM), which accounts
for 10~20% of heart failure and sudden death in children and youth. Viral proteases have been recognized as important
pathogenic mechanisms through the cleavage of important host proteins. However, the precise mechanisms underlying the
development of DCM remain unclear. Serum response factor (SRF) is a cardiac-enriched transcription factors regulating the
expression of a variety of target genes, including cardiac contractile/regulatory genes and microRNAs. SRF has been shown
to play a central role in cardiac development and function. We recently demonstrated that SRF is cleaved during enteroviral
infection through the action of viral protease 2A. This cleavage is accompanied by impaired cardiac function and downregulation
of cardiac specific contractile/regulatory genes. We further identified the cleavage site (before G327) and showed that cleavage
of SRF dissociates its DNA-binding domain from the transactivation domain, resulting in the loss of functional SRF and the
generation of a dominant-negative truncate of SRF which competes for DNA binding. Finally, based on the identified cleavage site
of SRF, we designed a modified SRF-based tetrapeptide (z-LKST-fmk) using a strategy similar to that used to inhibit caspases with
the peptide substrate analogue z-VAD-fmk. Our preliminary
in vitro
results demonstrated that this peptide inhibitor inhibits
SRF cleavage and reduces viral replication in cardiomyocytes. Novel therapeutic approaches are expected to be developed to
ameliorate myocardial damage and progression to DCM
in vivo.
Biography
Dr. Honglin Luo is an Associate Professor in the Department of Pathology and Laboratory Medicine/James Hogg Research Center at the University of British Columbia, Canada. Dr. Luo completed her MSc and MD training in China. She then pursued her postdoctoral training at the University of Washington. Dr. Luo has published over 60 refereed papers and served as an editorial board member of several journals.
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, 黑料网 Journals